F Clavel

2.6k total citations
25 papers, 2.1k citations indexed

About

F Clavel is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, F Clavel has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 13 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in F Clavel's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (5 papers). F Clavel is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (5 papers). F Clavel collaborates with scholars based in France, United States and Switzerland. F Clavel's co-authors include Pierre Charneau, Marc Alizon, Jan M. Orenstein, Andrew M. Borman, Esther Race, Sabine Yerly, Laurent Kaiser, Lionel Perrin, Sylvie Paulous and Tatjana Dragic and has published in prestigious journals such as The Lancet, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

F Clavel

25 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Clavel France 17 1.6k 1.1k 565 481 408 25 2.1k
Anthony de Ronde Netherlands 25 1.9k 1.2× 1.3k 1.1× 474 0.8× 483 1.0× 629 1.5× 54 2.4k
Babak Banapour United States 12 1.2k 0.8× 644 0.6× 267 0.5× 404 0.8× 639 1.6× 14 1.5k
R E Benveniste United States 17 1.0k 0.6× 519 0.5× 278 0.5× 423 0.9× 464 1.1× 20 1.5k
Janet E. Embretson United States 9 1.3k 0.8× 711 0.6× 244 0.4× 468 1.0× 617 1.5× 11 1.7k
Nafees Ahmad United States 22 1.2k 0.8× 915 0.8× 450 0.8× 360 0.7× 366 0.9× 55 1.8k
A. K. Fowler United States 18 840 0.5× 624 0.5× 272 0.5× 352 0.7× 542 1.3× 58 1.5k
Morgane Rolland United States 23 1.1k 0.7× 860 0.8× 602 1.1× 339 0.7× 689 1.7× 64 1.9k
Linda Morfeldt-Månson Sweden 10 1.4k 0.9× 966 0.8× 169 0.3× 433 0.9× 506 1.2× 17 1.7k
Faruk Sinangil United States 23 1.0k 0.7× 540 0.5× 364 0.6× 412 0.9× 608 1.5× 51 1.5k
R E de Goede Netherlands 12 2.6k 1.6× 1.6k 1.4× 287 0.5× 468 1.0× 1.3k 3.1× 13 2.9k

Countries citing papers authored by F Clavel

Since Specialization
Citations

This map shows the geographic impact of F Clavel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Clavel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Clavel more than expected).

Fields of papers citing papers by F Clavel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Clavel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Clavel. The network helps show where F Clavel may publish in the future.

Co-authorship network of co-authors of F Clavel

This figure shows the co-authorship network connecting the top 25 collaborators of F Clavel. A scholar is included among the top collaborators of F Clavel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Clavel. F Clavel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rato, Sylvie, et al.. (2014). Impact of the HIV integrase genetic context on the phenotypic expression and in vivo emergence of raltegravir resistance mutations. Journal of Antimicrobial Chemotherapy. 70(3). 731–738. 12 indexed citations
2.
Zolopa, Andrew, Laura C. Lazzeroni, F. B. Vezinet, et al.. (2005). Accuracy, Precision, and Consistency of Expert HIV Type 1 Genotype Interpretation: An International Comparison (The GUESS Study). Clinical Infectious Diseases. 41(1). 92–99. 8 indexed citations
3.
Cua, Éric, J. Durant, Ronan Boulmé, et al.. (2002). Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients. HIV Clinical Trials. 3(1). 36–44. 14 indexed citations
4.
Yerly, Sabine, et al.. (1999). Transmission of antiretroviral-drug-resistant HIV-1 variants. The Lancet. 354(9180). 729–733. 312 indexed citations
5.
Nascimbeni, Michelina, et al.. (1998). The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.. Journal of General Virology. 79(8). 1945–1950. 24 indexed citations
6.
Rey, F.A., Michelina Nascimbeni, M Courcoul, et al.. (1997). Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. Journal of Virology. 71(3). 2473–2477. 49 indexed citations
7.
Borman, Andrew M., Sylvie Paulous, & F Clavel. (1996). Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug. Journal of General Virology. 77(3). 419–426. 138 indexed citations
8.
Clavel, F & Pierre Charneau. (1994). Fusion from without directed by human immunodeficiency virus particles. Journal of Virology. 68(2). 1179–1185. 144 indexed citations
9.
Charneau, Pierre, Marc Alizon, & F Clavel. (1992). A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. Journal of Virology. 66(5). 2814–2820. 251 indexed citations
10.
Dragic, Tatjana, Pierre Charneau, F Clavel, & Marc Alizon. (1992). Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. Journal of Virology. 66(8). 4794–4802. 124 indexed citations
11.
Clavel, F. (1992). [New virological data: replication and persistence of the human immunodeficiency virus].. PubMed. 42(2). 142–7. 1 indexed citations
12.
Charneau, Pierre & F Clavel. (1991). A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. Journal of Virology. 65(5). 2415–2421. 130 indexed citations
13.
Clavel, F & Jan M. Orenstein. (1990). A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. Journal of Virology. 64(10). 5230–5234. 159 indexed citations
14.
Roulot, Dominique, Dominique Valla, Françoise Brun‐Vézinet, et al.. (1987). Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature.. Gut. 28(12). 1653–1660. 24 indexed citations
15.
Clavel, F. (1987). HIV-2 the West African AIDS virus. Editorial review.. AIDS. 1(3). 4 indexed citations
16.
Brun‐Vézinet, Françoise, Christine Katlama, Dominique Roulot, et al.. (1987). LYMPHADENOPATHY-ASSOCIATED VIRUS TYPE 2 IN AIDS AND AIDS-RELATED COMPLEX. The Lancet. 329(8525). 128–132. 97 indexed citations
17.
Venet, A, F Clavel, Dominique Israël‐Biet, et al.. (1986). Lung in acquired immune deficiency syndrome: infectious and immunological status assessed by bronchoalveolar lavage.. PubMed. 21(6). 535–43. 29 indexed citations
18.
Clavel, F, F. Brun-Vézinet, Denise Guétard, et al.. (1986). [LAV type II: a second retrovirus associated with AIDS in West Africa].. PubMed. 302(13). 485–8. 10 indexed citations
19.
Montagnier, Luc, F Clavel, Bernard Krust, et al.. (1985). Identification and antigenicity of the major envelope glycoprotein of of lymphadenopathy-associated virus. Virology. 144(1). 283–289. 131 indexed citations
20.
Montagnier, Luc, J C Chermann, Françoise Barré‐Sinoussi, et al.. (1984). Lymphadenopathy associated virus and its etiological role in AIDS.. PubMed. 15. 319–31. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026